Funder: National Institutes of Health

Due Dates: May 26, 2025 (Letter of Intent & Open Date) | June 26, 2025 (Application Due) | February 6, 2026 (Letter of Intent) | March 6, 2026 (Application Due) | March 9, 2026 (Expiration)

Funding Amounts: Up to $1,200,000 direct costs/year (max 3 years); NIH expects to fund 3–4 awards per cycle, with $5.5M/year committed.

Summary: Supports collaborative research using biosamples and/or data from type 1 diabetes clinical studies to advance understanding of disease mechanisms and improve prevention.

Key Information: Clinical trials are not allowed; applicants must have documented access to eligible biosamples/data at submission.